Figure 4.
Event-free survival (EFS) according to cyclin D1 expression. Median EFS was 33 months for patients who overexpressed cyclin D1 (group A) versus 24 months for patients who did not (group B) (P = .055).
Event-free survival (EFS) according to cyclin D1 expression. Median EFS was 33 months for patients who overexpressed cyclin D1 (group A) versus 24 months for patients who did not (group B) (P = .055).
